Last reviewed · How we verify
HSK44459 tablets
At a glance
| Generic name | HSK44459 tablets |
|---|---|
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study for HSK44459 in Participants With Atopic Dermatitis (PHASE2)
- A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease (PHASE2)
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) (PHASE2)
- Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease (PHASE2)
- Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |